 |
|
COMMENTS AND OPINIONS
Phacoemulsification Training—Reply
J. Bradley Randleman, MD;
Jeremy D. Wolfe, MD;
Maria A. Woodward, MD;
Sunil K. Srivastava, MD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank Masselos and colleagues for their interest in our article.1 We agree with their assertion that their studies referenced along with ours clearly demonstrate a procedural learning curve2; however, we do not advocate setting a firm number of 160 minimum cases necessary based on our results or anything currently in the literature.
While Masselos and colleagues find it concerning that visual acuity outcomes did not significantly improve throughout the course of our study, we find the fact reassuring because the visual outcomes of even the earliest of cases were very good, thus demonstrating the safety of early resident phacoemulsification cases with appropriate resident surgeon supervision.
Masselos and colleagues also found the fact that 44% of our study patients achieved 20/20 or better BSCVA "unacceptably low" compared with their study that . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
The Resident Surgeon Phacoemulsification Learning Curve
J. Bradley Randleman, Jeremy D. Wolfe, Maria Woodward, Michael J. Lynn, D. Hunter Cherwek, and Sunil K. Srivastava
Arch Ophthalmol. 2007;125(9):1215-1219.
ABSTRACT
| FULL TEXT
RELATED LETTER
Phacoemulsification Training
Katherine Masselos, Katelyn J.Y. Lee, Tani M. Brown, Louis W. Wang, Edwin C. Figueira, Vivek B. Pandya, and Ian C. Francis
Arch Ophthalmol. 2008;126(11):1608.
EXTRACT
| FULL TEXT
|
